Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trials
Phase 2 clinical trial for metastatic breast cancer therapy to proceed
May 5th, 2005
Kosan Biosciences Incorporated (KOSN) announced that its phase 2 clinical trial of KOS-862 (Epothilone D) as monotherapy for patients with metastatic breast cancer will proceed to full enrollment of the study following the successful completion of the interim analysis. The multi-center phase 2 study is being conducted according to a 2-stage Simon trial design, in which the primary objective must be met in the first stage of the trial before proceeding to the second stage. "The decision to proceed to the next step of this phase 2 study in breast cancer is encouraging. We are also evaluating KOS-862 in a phase 2 monotherapy trial in prostate cancer,...
Source: Women's Health Weekly (2005-05-05)
|
